As part of its efforts to ensure the supply of medical products from China during the ongoing coronavirus (COVID-19) outbreak, the US Food and Drug Administration (FDA) has identified 20 drugs that are made in or produced solely from active pharmaceutical ingredients (APIs) sourced from China.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,